Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
8.39
+0.04 (0.48%)
May 14, 2025, 2:45 PM CST
SHE:300009 Revenue
Anhui Anke Biotechnology (Group) had revenue of 628.75M CNY in the quarter ending March 31, 2025, a decrease of -4.17%. This brings the company's revenue in the last twelve months to 2.51B, down -14.31% year-over-year. In the year 2024, Anhui Anke Biotechnology (Group) had annual revenue of 2.54B, down -11.51%.
Revenue (ttm)
2.51B
Revenue Growth
-14.31%
P/S Ratio
5.59
Revenue / Employee
947.75K
Employees
2,647
Market Cap
14.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.54B | -329.71M | -11.51% |
Dec 31, 2023 | 2.87B | 534.69M | 22.94% |
Jan 1, 2023 | 2.33B | 162.30M | 7.48% |
Dec 31, 2021 | 2.17B | 467.35M | 27.47% |
Dec 31, 2020 | 1.70B | -11.11M | -0.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |